BioSpecifics Technologies Corp. Now Covered by JMP Securities (BSTC)
JMP Securities started coverage on shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) in a research note issued on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $28.00 price target on the stock. JMP Securities’ target price would suggest a potential upside of 47.60% from the company’s current price.
Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) traded up 2.42% during mid-day trading on Tuesday, hitting $19.43. The stock had a trading volume of 3,581 shares. BioSpecifics Technologies Corp. has a 52 week low of $12.52 and a 52 week high of $19.99. The stock’s 50-day moving average is $18.58 and its 200-day moving average is $17.12. The company has a market cap of $123.2 million and a P/E ratio of 33.28.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) last released its earnings data on Thursday, August 8th. The company reported $0.15 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.02 by $0.13. Analysts expect that BioSpecifics Technologies Corp. will post $0.60 EPS for the current fiscal year.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.